Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplanta

Go back to Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplanta
(NASDAQ: SANA) Delayed: 2.95 -0.01 (0.34%)
Previous Close $2.96    52 Week High $ 
Open $2.96    52 Week Low $ 
Day High $3.00    P/E N/A 
Day Low $2.90    EPS $ 
Volume 2,880,336